Lee C, Kao H, Lin H, P'eng F, Chi C
Department of Surgery, Veterans General Hospital-Taipei, Shih-pai, Taipei 11217, Taiwan, R.O.C.
Int J Mol Med. 1998 Aug;2(2):229-233.
Previously, we and others have found that the prognosis of patients with well differentiated thyroid cancer is related to patient age and gender. In this study, we examined estrogen and glucocorticoid receptors in thyroid cancers and adjacent non-neoplastic thyroid tissues from 31 Chinese patients. Our results indicate that the level of estrogen and glucocorticoid receptors in thyroid cancer tissues was similar to that in non-neoplastic thyroid tissues. Significant higher estrogen and glucocorticoid receptor levels were found in thyroid cancers from men than women. There was no difference in estrogen receptor levels from thyroid cancer in women less than or older than 45. However, the level of glucocorticoid receptor in thyroid cancer from women less than 45 years old was significantly higher than that of women older than 45. Estrogen or glucocorticoid receptor levels did not correlate with tumor invasiveness. The pathobiological role of glucocorticoid receptors in thyroid cancer is not known but may be involved in changes in circadian rhythm of thyroid tumors.
此前,我们和其他人发现,高分化甲状腺癌患者的预后与患者年龄和性别有关。在本研究中,我们检测了31例中国患者甲状腺癌组织及相邻非肿瘤性甲状腺组织中的雌激素和糖皮质激素受体。我们的结果表明,甲状腺癌组织中雌激素和糖皮质激素受体水平与非肿瘤性甲状腺组织相似。男性甲状腺癌中雌激素和糖皮质激素受体水平显著高于女性。45岁以下或45岁以上女性甲状腺癌的雌激素受体水平无差异。然而,45岁以下女性甲状腺癌中糖皮质激素受体水平显著高于45岁以上女性。雌激素或糖皮质激素受体水平与肿瘤侵袭性无关。糖皮质激素受体在甲状腺癌中的病理生物学作用尚不清楚,但可能参与甲状腺肿瘤昼夜节律的变化。